Zymeworks appoints Leone Patterson as EVP, Chief Business & CFO effective Sept 1, 2024

Zymeworks Inc.

Ms. Patterson appointed EVP, Chief Business Officer and CFO; start date Sept 1, 2024.
Kenneth Galbraith to step down as interim CFO but remain Chair and CEO.
Compensation: $485K base salary, 45% bonus target, $50K signing bonus, 360,000 inducement stock options.
Amended Inducement Plan increases share reserve by 700,000 shares to 1,450,000 total since plan inception.
Ms. Patterson brings over 20 years biotech CFO/CEO experience from Tenaya, Adverum, etc.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Leone Patterson

Executive Vice President, Chief Business Officer and Chief Financial Officer

ZYME · Zymeworks Inc.

Effective: 2024-09-01
Filed: July 25, 2024, 7:59 PM ET

On July 19, 2024, the Board of Directors (the “Board”) of Zymeworks Inc. (the “Company”) appointed Ms. Leone Patterson, age 61, as Executive Vice President, Chief Business Officer and Chief Financial Officer of the Company, effective upon her commencement of employment with the Company, which is anticipated to be September 1, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leone Patterson was appointed as Executive Vice President, Chief Business Officer and Chief Financial Officer at Zymeworks Inc..

Action: appointed
Role: Executive Vice President, Chief Business Officer and Chief Financial Officer

Exact text from the filing

On July 19, 2024, the Board of Directors (the “Board”) of Zymeworks Inc. (the “Company”) appointed Ms. Leone Patterson, age 61, as Executive Vice President, Chief Business Officer and Chief Financial Officer of the Company, effective upon her commencement of employment with the Company, which is anticipated to be September 1, 2024

View on SEC.gov

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-184871

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.